Respiratory medicine and researchHumansCarcinomaNon-Small-Cell LungLung NeoplasmsMale
Real-world management of unresectable stage III non-small-cell lung cancer: Impact of durvalumab consolidation therapy in French clinical practice.
Christos Chouaid, Philippe Giraud, Marie Wislez, Eric Pichon, Alma Stancu, Didier Debieuvre, Nicolas Girard, Maurice Pérol, Xavier Quantin, Sabine Ano, Françoise Grela, Nina Goyard, Mathieu Fore, Fanny Magne, Vanessa Pante
Published: 202510.1016/j.resmer.2025.101216
Abstract
BACKGROUND: Durvalumab consolidation therapy has improved survival after chemoradiotherapy in patients with advanced non-small-cell lung cancer (NSCLC). Our three-cohort study from France described the real-world effectiveness and safety of durvaluma…
Preview only. Read the full abstract at the source